C. Hussey
Good afternoon, and welcome to Huron Consulting Group's First Quarter 2024 Earnings Call. With me today are John Kelly, our Chief Financial Officer; and Ronnie Dail, our Chief Operating Officer. Our first quarter revenue -- I'm sorry, our first quarter results reflect our ongoing focus on achieving consistent revenue growth and margin expansion. Revenues grew 12% over the first quarter of 2023, driven by strong growth in our Healthcare segment as well as continued growth in our Education segment, which furthers the segment's multiyear growth trajectory. Our strong growth in the first quarter of 2023 was achieved on top of strong growth in the year ago quarter with Q1 2023 growth of 22% over the first quarter of 2022. Our first quarter results also demonstrate our commitment to delivering on the growth strategy and financial goals shared at our 2022 Investor Day, consisting of low double-digit annual revenue growth and expanding our adjusted EBITDA margins to mid-teen levels, leading to an annual high-teen percentage adjusted EPS growth. We believe achieving our financial goals together with a balanced capital deployment strategy that prioritizes moderate leverage, share repurchase and targeted M&A will drive strong returns for our shareholders over time. I'll now share some additional insight into the progress we've made on our strategy while providing color into our first quarter performance. As a reminder, to achieve our goals, we're committed to executing against 5 strategic pillars. The first pillar of our strategy is to continue accelerating growth in our largest industries, health care and education, where we're focused on building upon our leading competitive positions. In the Healthcare segment, first quarter revenues grew 21% over the prior year quarter. The increase in revenues in Q1 of 2024 was driven by strong broad-based demand across our performance improvement, digital, strategy and innovation and financial advisory offerings. The operating environments for many health care organizations are mixed in recent months. Some health systems continue to face strained financial positions, driving continued demand for our performance improvement and distressed focused financial advisory offerings. Other health care providers have seen margins improved, and they're now seeking opportunities to evolve their strategies and advance their competitive positions by making strategic and operational investments. These organizations are creating demand for our digital, strategy and innovation and nondistressed financial advisory offerings. As part of Huron's growth strategy, we continue to diversify our Healthcare service portfolio over time to meet the broader needs in the market, which has yielded greater consistency in this segment's financial performance. We've expanded the offerings within our performance improvement business while growing our Healthcare-focused strategy innovation, digital and financial advisory offerings. If you look back to 2014, 10 years ago, our performance improvement offerings represented virtually 100% of segment revenues. Fast forward to 2023, we diversified our portfolio so that performance improvement offerings represent only 46% of Healthcare segment revenues. We're confident that these investments we're making to expand our health care offerings are paying off, and we believe we're well positioned to address the wide array of opportunities and challenges facing our hospital and health system clients. Education segment revenues grew 7% in the first quarter of 2024 over the prior year quarter, driven by strong demand for our digital services and products. The education industry continues to face wide-ranging pressures, from top line challenges, including difficulty meeting enrollment and fundraising goals, more challenging research funding sources to cost and regulatory pressures, including increased government governmental scrutiny, workforce disruptions and the need to make significant technology investments. The clients require a broad array of services and products to help them address these issues. We continue to strengthen and expand our offerings in the education industry to comprehensively address our clients' needs. We're the leading firm in the industry serving research institutions. The challenges of managing the highly complex research enterprises are increasing due to declines in funding for federal and commercial research and increased cost to conduct research. Research mission is critical to our client base, and our research businesses continue to be a strong source of growth for our Education segment and a differentiator for our services among the most prominent research institutions. We continue to invest in strengthening our offerings in this area, including our Huron Research Suite software, which is the predominant product in the market with over 600,000 users and over 500 institutions. The strength of our offering has yielded the client retention rate of over 99% across our suite of products. We also continue to expand our offerings to serve the broader needs of our mission-driven clients, particularly in education. For example, a recent acquisition of GG+A, one of the top philanthropy consulting firms, is creating new opportunities not only in education but also across health care and other non-for-profit clients. Another example of our expanded offerings is our athletics practice. We began to focus on university athletics in 2020. And to date, we have worked with over 50 institutions, ranging from the top Division 1 conferences to FCS and smaller institutions, many of which are facing increasingly complicated operating environments stemming from the dramatic changes taking place in intercollegiate athletics. We help these organizations to evaluate and execute upon the conference and athletic department strategies, which often have an outsized impact on the financials, enrollment and branding of our large academic clients. Our Healthcare and Education businesses have market tailwinds, which continue to propel their growth. Our leading competitive positions, deep client relationships, high-quality delivery and wide array of offerings position us well to be the partner of choice for our health system, university and research-focused clients. Our second strategic pillar is focused on growing our commercial industry presence. In the first quarter of 2024, Commercial segment revenues were largely flat, driven by increases in revenue for our financial advisory offerings, partially offset by declines in our strategy and innovation and digital offerings. We continue to see our commercial clients taking a more cautious approach to executing large-scale initiatives and strategy-related engagements as uncertainties in the macroeconomic environment persist. Our distressed financial advisory business continues to have a solid outlook, although at a more moderate level than the strong record results achieved in 2023. With our focused strategy, we believe the commercial industries will create new avenues of growth for Huron. The mix of our digital, strategy and financial advisory offerings has created a more balanced portfolio from which we can continue to grow our presence in financial services, industrials and manufacturing and energy and utilities while providing more consistency in our financial performance in different market cycles. Now let me turn to our third strategic pillar, advancing our integrated Digital platform. In the first quarter of 2024, Digital capability revenues grew 10% over the first quarter of 2023, driven by growth across the Healthcare and Education segments. In 2023, our Digital capability grew to over $0.5 billion, a key milestone for that business and a testament to the collective investments we've made in technology, data and analytics across all industries. We continue to be a market leader in our digital offerings. We were named best in class in health care for ERP business transformation and implementation leadership as well as IT consulting services in the payer market. We've also been awarded recognitions for driving innovation by other technology partners. And we're incredibly proud of the work we're doing and how we continue to expand our offerings to meet the rapidly evolving technology, data and analytics needs of our clients. Intelligent automation, including the use of generative AI, is one area that is of great prominence and exploration on the market today. Our automation, analytics and AI services revenues grew to over $50 million in 2023, demonstrating the value we bring to our clients and the growing significance of these advanced technologies in the market. Our work today spans advising clients on their intelligent automation strategies and road maps, including the data foundation needed to be successful through to the implementation of distinct use cases and comprehensive intelligent automation programs. And we provide 2 brief examples of how we're working with clients to apply AI. First, we're working with a commercial plan to establish a centralized AI capability center that will provide a platform to responsibly govern their AI program while also incubating high impact solutions across their business. Second, we're working with a health system to leverage generative AI to expedite the clinical appeals process as part of their revenue cycle to reduce the administrative burden of inefficient reimbursement. These are only 2 examples of many that we're leaning in to enable our clients' businesses through the use of AI. Expanding our digital capabilities, including our intelligent automation offerings, through organic and inorganic investments will continue to be an important driver of growth across our business for many years to come as our clients focus on driving growth and productivity in their own highly competitive markets through the use of technology, data and analytics. Now let me turn to our last 2 strategic pillars, which are more financially focused. First, we're executing on our margin improvement levers to achieve enhanced profitability. As it relates to margin expansion, a company-wide focus on improving profitability has yielded solid results. In 2020 to 2023, our full year adjusted EBITDA margin has increased 200 basis points, and full year adjusted diluted earnings per share has increased 128%. We continue to feel confident in our ability to improve our margins across our robust global platform, which will drive further efficiency as we scale while continuing our focus in areas such as driving improved utilization, pricing realization and SG&A leverage. Our final pillar focuses on deploying capital to accelerate our strategy and return capital to our shareholders. Since our Investor Day in March of 2022 and through the quarter just ended, we repurchased 3.6 million shares at a weighted average price of $78.36, representing 16.5% of our common stock outstanding as of December 31, 2021. In 2024, we expect to execute our balanced capital allocation strategy across share repurchases, debt repayment and tuck-in acquisitions. We believe that combining the capabilities and talent from acquisitions to enhance our competitive position, such as the recent GG+A acquisition, will drive strong growth and returns for our shareholders. And finally, let me acknowledge the heart of our strategy, our people. We have and will continue to invest in our incredibly talented team and strong collaborative culture. Our competitive advantage is driven by the strength and depth of our team. And our company culture, which drives how we work together and to deliver on the most complex challenges of our clients creates an environment where we're constantly innovating new offerings and advancing our business collectively as a unified team. Our ability to attract and retain top talent is demonstrated by our headcount growth of 41% from the end of 2021 to the end of 2023, coupled with consistently low attrition and high engagement scores. Our distinct culture, coupled with strong career advancement and development opportunities, provides a stable platform of ongoing growth not only for our people but also for our business. And now let me turn to our outlook for the year. Today, we affirm our 2024 revenue and adjusted EBITDA margin guidance, and we're raising our adjusted earnings per share guidance to a range of $5.60 to $6.10. We continue to believe our growth trajectory is strong given the expected demand in our end markets across health care, education and commercial, our strong competitive positions and our deep client relationships. Given our focus, we have a unique breadth in our offerings, depth in our talent and relevance in our subject matter expertise that allows us to be nimble and innovative yet have the credentials and experience to compete and win against much larger competitors. Let me close by saying that our commitment to our growth strategy is evident in our recent performance, including our first quarter results. Our progress would not be possible without the focus and dedication of our entire team, and I want to thank all of them for supporting each other, our clients and our business as we strive to make a lasting impact in the work that we do each and every day. Now let me turn it over to John for a more detailed discussion of our financial results. John?